Who has invested in Humacyte?

No investors are named on the public record for Humacyte yet.

Humacyte Funding: $245M Raised, IPO (2021)

Humacyte funding overview

Humacyte is based in Durham. Humacyte has raised $245M in total disclosed funding. That places its disclosed total in the $100M–$250M range. Its most recent disclosed round is an IPO announced in August 2021. The round record for Humacyte runs through 2021; nothing later has been disclosed.

Humacyte at a glance

Total raised: $245M
Latest round: IPO
Latest round date: August 2021
Headquarters: Durham

Frequently asked about Humacyte funding

How much has Humacyte raised?: Humacyte has raised $245M in total disclosed funding across the rounds on record.
Who has invested in Humacyte?: No investors are named on the public record for Humacyte yet.
What was the latest Humacyte funding round?: The most recent disclosed round is an IPO, announced in August 2021.
Where is Humacyte based?: Humacyte is based in Durham.
When did Humacyte last raise?: The last disclosed Humacyte round closed in August 2021 at IPO.

Totals shown for Humacyte aggregate every disclosed round on file. To see how that compares, browse the companies in Durham and the investors behind them below.

Humacyte Funding: $245M Raised, IPO (2021)

Humacyte funding overview

Humacyte at a glance

Frequently asked about Humacyte funding

Companies related to Humacyte (18)

Browse related funding lists (3)